Procedural complication and long term outcomes after alcohol septal ablation in patients with obstructive hypertrophic cardiomyopathy: data from China

被引:15
作者
An, Shuo-yan [1 ,2 ]
Yang, Yin-jian [1 ,2 ]
Hang, Fei [1 ,2 ]
Wang, Zhi-min [2 ,3 ]
Fan, Chao-mei [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Key Lab Clin Trial Res Cardiovasc Drugs, Minist Hlth, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, Dept Ultrasound, Beijing, Peoples R China
关键词
TASK-FORCE; FOLLOW-UP; MYECTOMY; SURVIVAL; METAANALYSIS; GUIDELINE; DIAGNOSIS; DEATH; YOUNG;
D O I
10.1038/s41598-017-10144-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on procedural complications and long term survival after alcohol septal ablation (ASA) in Chinese patients with obstructive hypertrophic cardiomyopathy (HOCM) are lacking. We aimed to investigate long-term survival of HOCM patients after ASA and compared to the non-obstructive hypertrophic cardiomyopathy(NOHCM). A total of 233 patients with HOCM and a peak pressure gradient of >= 50 mm Hg at rest or with provocation were consecutively enrolled from Fuwai Hospital in China between 2000 and 2012. Another 297 patients without left ventricular outflow tract obstruction were regarded as control group. Periprocedural mortality of ASA were low (0.89%). Periprocedural lethal ventricular arrhythmia occurred in 9 patients (4.0%). Alcohol volume (RR 1.44, 95% CI: 1.03-2.03, P = 0.034) and age <= 40 years old (RR 4.63, 95% CI: 1.07-20.0, P = 0.040) were independent predictors for periprocedural lethal ventricular arrhythmia. The 10-year overall survival was 94.6% in the ASA group, similar with 92.9% in the NOHCM group (P = 0.930). In conclusion, periprocedural mortality and complications were rare in ASA. Long term survival after ASA were satisfactory and comparable to NOHCM. Patients under 40 years old should be more cautious undergoing ASA, for these patients were more likely to endure lethal ventricular arrhythmia during periprocedural period of ASA.
引用
收藏
页数:7
相关论文
共 33 条
[1]   Updated Meta-Analysis of Septal Alcohol Ablation Versus Myectomy for Hypertrophic Cardiomyopathy [J].
Agarwal, Shikhar ;
Tuzcu, E. Murat ;
Desai, Milind Y. ;
Smedira, Nicholas ;
Lever, Harry M. ;
Lytle, Bruce W. ;
Kapadia, Samir R. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (08) :823-834
[2]   Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis [J].
Alam, Mahboob ;
Dokainish, Hisham ;
Lakkis, Nasser M. .
EUROPEAN HEART JOURNAL, 2009, 30 (09) :1080-1087
[3]  
[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105
[4]   Long-Term Survival in Patients With Resting Obstructive Hypertrophic Cardiomyopathy Comparison of Conservative Versus Invasive Treatment [J].
Ball, Warren ;
Ivanov, Joan ;
Rakowski, Harry ;
Wigle, E. Douglas ;
Linghorne, Meredith ;
Ralph-Edwards, Anthony ;
Williams, William G. ;
Schwartz, Leonard ;
Guttman, Ashley ;
Woo, Anna .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (22) :2313-2321
[5]   ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography) [J].
Cheitlin, MD ;
Armstrong, WF ;
Aurigemma, GP ;
Beller, GA ;
Bierman, FZ ;
Davis, JL ;
Douglas, PS ;
Faxon, DP ;
Gillam, LD ;
Kimball, TR ;
Kussmaul, WG ;
Pearlman, AS ;
Philbrick, JT ;
Rakowski, H ;
Thys, DM ;
Antman, EM ;
Smith, SC ;
Alpert, JS ;
Gregoratos, G ;
Anderson, JL ;
Hiratzka, LF ;
Faxon, DP ;
Hunt, SA ;
Fuster, V ;
Jacobs, AK ;
Gibbons, RJ ;
Russell, RO .
CIRCULATION, 2003, 108 (09) :1146-1162
[6]   Effects of alcohol septal ablation on left ventricular diastolic filling patterns in obstructive hypertrophic cardiomyopathy [J].
Chen, You-Zhou ;
Duan, Fu-Jian ;
Yuan, Jian-Song ;
Hu, Feng-Huan ;
Cui, Jin-Gang ;
Yang, Wei-Xian ;
Zhang, Yan ;
Wang, Hao ;
Qiao, Shu-Bin .
HEART AND VESSELS, 2016, 31 (05) :744-751
[7]   Effectiveness and Safety Beyond 10 Years of Percutaneous Transluminal Septal Ablation in Hypertrophic Obstructive Cardiomyopathy [J].
de la Torre Hernandez, Jose M. ;
Masotti Centol, Monica ;
Lerena Saenz, Piedad ;
Sanchez Recalde, Angel ;
Gimeno de Carlos, Federico ;
Pinon Esteban, Pablo ;
Fernandez Rodriguez, Diego ;
Sitges Carreno, Marta ;
Sabate Tenas, Manel ;
Zueco Gil, Javier .
REVISTA ESPANOLA DE CARDIOLOGIA, 2014, 67 (05) :353-358
[8]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[9]   Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy The Baylor and Medical University of South Carolina Experience 1996 to 2007 [J].
Fernandes, Valerian L. ;
Nielsen, Christopher ;
Nagueh, Sherif F. ;
Herrin, Amy E. ;
Slifka, Christine ;
Franklin, Jennifer ;
Spencer, William H., III .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (05) :561-570
[10]  
Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230